Frequently expressed glypican‐3 as a promising novel therapeutic target for osteosarcomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Frequently expressed glypican‐3 as a promising novel therapeutic target for osteosarcomas

Published:2022-08-21 Issue:10 Volume:113 Page:3618-3632
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Nie Jun‐Hua¹,Yang Tao²,Li Hong³,Li Sheng³,Li Ting‐Ting³,Ye Hai‐Shan¹,Lu Meng‐Di¹,Chu Xiao²,Zhong Guo‐Qing²,Zhou Jie‐Long²,Wu Mo‐Li⁴,Zhang Yu²,Liu Jia¹⁴^ORCID

Affiliation:

1. South China University of Technology School of Medicine Guangzhou China

2. Department of Orthopedic Oncology Guangdong Provincial People's Hospital Affiliated to South China University of Technology School of Medicine Guangzhou China

3. BioMed Laboratory, Guangzhou Jingke Biotech Group Guangzhou China

4. Liaoning Laboratory of Cancer Genomics and Epigenomics, College of Basic Medical Sciences Dalian Medical University Dalian China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15521

Reference52 articles.

1. International trends in incidence of osteosarcoma (1988‐2012)

2. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

3. Cancer statistics, 2020

4. Osteosarcoma

5. Osteosarcoma, Chondrosarcoma, and Chordoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Self-Assembling Immune-Featured Osteosarcoma Patient/PDX Derived Organoid Model and Biobank for Personalized Immune Therapy;2024-08-11

2. PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT;Cancer Research;2024-06-20

3. Exploring tumor organoids for cancer treatment;APL Materials;2024-06-01

4. Organoids as a new approach for improving pediatric cancer research;Frontiers in Oncology;2024-05-21

5. Deprivation of methionine inhibits osteosarcoma growth and metastasis via C1orf112-mediated regulation of mitochondrial functions;Cell Death & Disease;2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3